LIPOCINE INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $2.0M | $11.2M | $-2.9M | $500.0K | $16.1M | $0 | $165.0K |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $8.6M | $7.4M | $10.2M | $8.6M | $7.7M | $9.7M | $7.5M |
| SG&A Expense | — | $3.8M | $5.0M | $4.9M | $4.1M | $5.3M | $8.2M | $5.6M |
| Operating Income | — | $-10.4M | $-1.2M | $-17.9M | $-12.1M | $3.1M | $-18.0M | $-12.9M |
| Operating Margin | — | -524.7% | -10.3% | 629.0% | -2,423.9% | 19.5% | — | -7,818.8% |
| Interest Expense | — | — | — | — | $27.1K | $203.3K | $386.6K | $766.7K |
| Pretax Income | — | $-9.6M | $9.0K | $-16.4M | $-10.8M | $-634.2K | $-21.0M | $-13.0M |
| Income Tax Expense | — | $200 | $681 | $755 | $681 | $200 | $200 | $200 |
| Net Income | — | $-9.6M | $8.4K | $-16.4M | $-10.8M | $-634.4K | $-21.0M | $-13.0M |
| Net Margin | — | -487.1% | 0.1% | 573.6% | -2,151.7% | -3.9% | — | -7,883.7% |
| EPS (Basic) | — | $-1.77 | — | $-3.10 | $-2.06 | $-0.01 | $-0.38 | $-0.25 |
| EPS (Diluted) | — | $-1.69 | — | $-3.14 | $-2.15 | $-0.01 | $-0.38 | $-0.25 |
| Shares Outstanding (Basic) | 7.3M | 5.4M | 5.3M | 5.3M | 5.2M | 86.9M | 55.7M | 51.8M |
| Shares Outstanding (Diluted) | 7.3M | 5.7M | 5.4M | 5.3M | 5.3M | 87.6M | 55.7M | 51.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |